Sign in
4

Changes in Ownership

Denali Therapeutics Inc. Filed Acc 0001209191-21-023846

Chief Medical Officer sold 2,822 shares at $54.62 ($154,126)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Ho Carole Chief Medical Officer 2021-03-29 Sale −2,822 $54.62 $154,126 162,319 I: show line 1 in the form
Open-market sales · 2,822 sh · avg $54.62 · $154,126
Loading xslF345X03/doc4.xml…